Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
In Bad Homburg, Germany, on May 28, 2026, Fresenius Medical Care (FME), a global leader in renal disease products and services, revealed the initiation of the initial phase of its share buyback scheme, encompassing roughly EUR 1 billion.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments